subchapter_subject: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"
part_code: "520"
part_subject: "ORAL DOSAGE FORM NEW ANIMAL DRUGS"
subpart_code: "B"
subpart_subject: "Specific Administrative Rulings and Decisions"
section_number: "520.1367"
section_subject: "Meloxicam."
cfr_reference: "21 CFR 520.1367"
title_name: "Title 21"
title_subject: "Food and Drugs"
parts_covered: "Parts 500 to 599"
revised_date: "Revised as of April 1, 2019"
publication_date: "As of April 1, 2019"
contains_description: "Containing a codification of documents of general applicability and future effect"
publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"
---
(a)Specifications—(1) Each milliliter of suspension contains 0.5 milligrams (mg) meloxicam.
(2)Each milliliter of suspension contains 1.5 mg meloxicam.
(b)Sponsors. See sponsors in § 510.600(c) of this chapter for uses as in paragraph (c) of this section:
(1)No. 000010 for use of the products described in paragraph (a) of this section; and
(2)Nos. 013744 and 055529 for use of the product described in paragraph (a)(2) of this section.
(c)Conditions of use in dogs—(1) Amount. Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on the first day of treatment. For all treatment after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.
(2)Indications for use. For the control of pain and inflammation associated with osteoarthritis.
(3)Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.